Carmen Bax

Papers

Total Citations

H-Index

About

Dr. Carmen Bax is a pioneering researcher in the field of biomedical sensing and non-invasive disease diagnostics, with a particular focus on volatile organic compound (VOC) analysis for cancer detection. Her key research areas encompass electronic nose (eNose) technology, urine odor profiling, and the development of low-cost, point-of-care diagnostic tools for prostate cancer risk stratification. Dr. Bax’s most notable contribution is her groundbreaking 2024 study, "Prostate cancer risk stratification via eNose urine odor analysis: a preliminary report," which has already garnered 3 citations since its recent publication. This work introduces a novel, non-invasive approach to distinguishing between low-risk and aggressive prostate cancer by analyzing urinary VOCs with an eNose—a method that could significantly reduce unnecessary biopsies and overtreatment. Her research addresses a critical clinical challenge: the over-diagnosis of indolent prostate cancers. By pioneering odor-based biomarkers, Dr. Bax is advancing the frontier of personalized oncology. Her achievements highlight a commitment to translating sensor technology into practical, patient-friendly screening tools, making her a rising leader in the intersection of analytical chemistry and clinical urology.